PHARMACOKINETICS AND SAFETY OF A PHENYTOIN PRODRUG GIVEN IV OR IM IN PATIENTS

被引:78
作者
LEPPIK, IE
BOUCHER, BA
WILDER, BJ
MURTHY, VS
WATRIDGE, C
GRAVES, NM
RANGEL, RJ
RASK, CA
TURLAPATY, P
机构
[1] UNIV MINNESOTA,COLL PHARM,MINNEAPOLIS,MN 55455
[2] MINCEP EPILEPSY CARE PA,MINNEAPOLIS,MN
[3] UNIV TENNESSEE,CTR HLTH SCI,COLL PHARM,MEMPHIS,TN 38163
[4] UNIV TENNESSEE,CTR HLTH SCI,COLL MED,MEMPHIS,TN 38163
[5] UNIV FLORIDA,DEPT NEUROL,GAINESVILLE,FL 32611
[6] SAMARITAN HOSP CTR,DEPT MED,MILWAUKEE,WI
[7] DUPONT CRIT CARE,CHICAGO,IL
关键词
D O I
10.1212/WNL.40.3_Part_1.456
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:456 / 460
页数:5
相关论文
共 29 条
[1]   DETERMINATION OF PKA VALUE FOR 5,5-DIPHENYLHYDANTOIN [J].
AGARWAL, SP ;
BLAKE, MI .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1968, 57 (08) :1434-&
[2]  
BROUMER K, 1988, CLIN PHARMACOL THER, V43, P178
[3]   CONCENTRATION-TIME PROFILE OF PHENYTOIN AFTER ADMIXTURE WITH SMALL VOLUMES OF INTRAVENOUS FLUIDS [J].
CLOYD, JC ;
BOSCH, DE ;
SAWCHUK, RJ .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1978, 35 (01) :45-48
[4]   INTRAVENOUS PHENYTOIN IN ACUTE TREATMENT OF SEIZURES [J].
CRANFORD, RE ;
LEPPIK, IE ;
PATRICK, B ;
ANDERSON, CB ;
KOSTICK, B .
NEUROLOGY, 1979, 29 (11) :1474-1479
[5]  
DUKES GE, 1988, PHARMACOTHERAPY, V8, P133
[6]   COMPLICATIONS OF INTRAVENOUS PHENYTOIN FOR ACUTE TREATMENT OF SEIZURES - RECOMMENDATIONS FOR USAGE [J].
EARNEST, MP ;
MARX, JA ;
DRURY, LR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (06) :762-765
[7]   SAFETY, TOLERANCE AND PHARMACOKINETICS OF INTRAVENOUS DOSES OF THE PHOSPHATE ESTER OF 3-HYDROXYMETHYL-5,5-DIPHENYLHYDANTOIN - A NEW PRODRUG OF PHENYTOIN [J].
GERBER, N ;
MAYS, DC ;
DONN, KH ;
LADDU, A ;
GUTHRIE, RM ;
TURLAPATY, P ;
QUON, CY ;
RIVENBURG, WK .
JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 28 (11) :1023-1032
[8]  
JAMERSON BD, 1988, CLIN PHARMACOL THER, V43, P178
[9]  
KOSTENBAUDER HB, 1975, CLIN PHARMACOL THER, V18, P449
[10]  
LAI CM, 1986, ACTA PHARMACOL TOX, V59, P213